NL
DE
A Nijmegen-based public-private partnership received 1.5 million Euro from the European Fund for Regional Development (EFRO).
With this grant, the consortium aims to develop novel therapeutics against mosquito-transmitted tropical infectious diseases, such as Malaria, dengue virus and Zika virus.
The consortium consists of the spinoff companies Protinhi Therapeutics, TropIQ Health Sciences, both based at the Novio Tech Campus, and scientists from Radboud University (dr. Martin Feiters, prof. Floris Rutjes) and Radboud University Medical Center (dr. Ronald van Rij, prof. Robert Sauerwein).
More information (in Dutch): read more.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Grants for research on magnesium deficiency and malaria Vidis for Felix Hol and Jeroen de Baaij
1 July 2022 Radboudumc researchers Jeroen de Baaij and Felix Hol both receive an NWO Vidi grant for their research, respectively on magnesium deficiency in type 2 diabetes and on malaria. read more
Veni grants for RIMLS researchers
16 December 2021 NWO has awarded 89 promising young scientists Veni funding of up to 280,000 euros. Three of them are from Radboud Institute of Molecular Life Sciences (RIMLS). They can develop their own research ideas over a period of three years. read more
Two science talents to foreign top institutes with Rubicon
21 June 2021Rubicons for Michelle Brouwer and Guido van Mierlo
read more
Rebecca Halbach receives idea generator grant to fight mosquito transmitted viruses
8 July 2020Rebecca Halbach and Pascal Miesen have investigated in a collaborative project whether the treatment of mosquitoes with antiviral drugs can prevent the transmission of mosquito-transmitted viral diseases.
read more
Three VIDI grants for RIMLS researchers
24 May 2019 Matthijs Jore, Daniele Tauriello and Johannes Textor are each to receive up to 800,000 euros to develop an innovative research theme and to build up their own research group. NWO is awarding the Vidi grant as part of the Innovational Research Incentives Scheme. read more
